hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
about
Regulation of hTERT by BCR-ABL at multiple levels in K562 cells.The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantationBmi-1, stem cells and cancer.Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemiasTelomere dysfunction and its role in haematological cancer.Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases.Dynamic length changes of telomeres and their nuclear organization in chronic myeloid leukemia.Role of the functional MNS16A VNTR-243 variant of the human telomerase reverse transcriptase gene in progression and response to therapy of patients with non-Hodgkin's B-cell lymphomas.Nuclear remodeling of telomeres in chronic myeloid leukemia.Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma.A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells.Role of hTERT and WT1 gene expression in disease progression and imatinib responsiveness of patients with BCR-ABL positive chronic myeloid leukemia.
P2860
Q34094028-CFB5248E-7405-407D-9793-2F6CF215B76CQ34544862-39805E2E-17EA-47C6-9400-03E702704ABFQ37541792-66BBAE16-F9A3-4484-8B4C-B4E099D377D0Q37589603-4954F667-C0E2-400B-BFCB-A66F92A71170Q37974664-72AD3B15-8E07-4420-9EB7-1301DDAAAF82Q39780065-9E58933A-2035-4CE9-BC1C-A5AB03DE4759Q42667277-012989A1-71CD-498A-A83E-E3DE189523C8Q44058153-46270E83-191D-41E9-8BA9-90AA602A1DF8Q45156146-417F707A-64F0-45F7-8A70-BFFD007FF419Q46615370-FD0D1A7C-670D-4350-BF20-83A8EE81FD4AQ47635411-F91FA2B3-141C-482C-BBD0-AB5DF1C384D1Q53150031-2E96C292-BD98-4FBB-AEA1-E13FA3E0A603Q54613673-A57FF25B-B81E-49A9-A14E-50439D4AC368
P2860
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
hTERT, the catalytic component ...... ith chronic myeloid leukaemia.
@en
hTERT, the catalytic component ...... ith chronic myeloid leukaemia.
@nl
type
label
hTERT, the catalytic component ...... ith chronic myeloid leukaemia.
@en
hTERT, the catalytic component ...... ith chronic myeloid leukaemia.
@nl
prefLabel
hTERT, the catalytic component ...... ith chronic myeloid leukaemia.
@en
hTERT, the catalytic component ...... ith chronic myeloid leukaemia.
@nl
P2093
P2860
P356
P1433
P1476
hTERT, the catalytic component ...... ith chronic myeloid leukaemia.
@en
P2093
Campbell LJ
Eagleton H
Littlewood TJ
Wainscoat JS
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404141
P577
2006-04-01T00:00:00Z